Enhanced Catalytic Efficiency
Directed evolution yields GOx variants with higher reaction speeds (k}_{\text{cat}) and improved affinity for the substrate, boosting conversion rate.
Glucuronic Acid (GlcA) is a carbohydrate acid vital in detoxification and drug metabolism in humans, used in the food and pharmaceutical industries. Industrial production is typically enzymatic or fermentation-based. However, the enzymatic route using Glucose Oxidase (GOx) and Uronate Dehydrogenase suffers from low conversion rate in enzyme synthesis due to enzyme instability and substrate/product inhibition. Fermentation often leads to many by-products in fermentation (e.g., gluconic acid, oxalic acid), complicating purification and reducing yield. A highly specific, high-yield biological route is needed.
CD Biosynsis offers a synthetic biology service focused on highly efficient and specific GlcA production. Our core strategy involves directed evolution of Aspergillus niger Glucose Oxidase (GOx) . We engineer GOx variants with enhanced thermal stability, higher catalytic efficiency, and improved selectivity toward the Glucuronic Acid pathway intermediates. This is coupled with the optimization of fermentation conditions , specifically fine-tuning pH, temperature, and dissolved oxygen levels to favor the action of the engineered GOx and minimize side reactions and byproduct formation. This integrated approach aims to deliver a high-yield, high-purity, and cost-effective Glucuronic Acid product.
Get a QuoteDeveloping a robust Glucuronic Acid production process faces these key challenges:
An effective solution must boost enzyme performance, maximize GlcA specificity, and simplify downstream processing.
CD Biosynsis utilizes advanced enzyme and fermentation engineering to optimize Glucuronic Acid production:
Directed Evolution of Aspergillus niger Glucose Oxidase
We perform high-throughput screening of GOx libraries to identify variants with significantly higher activity and improved stability under industrial conditions.
Optimization of Fermentation Conditions
We fine-tune pH, temperature, and aeration strategies to create an environment that maximizes the conversion efficiency of the target pathway and suppresses side reactions.
Byproduct Pathway Knockout
In fermentation hosts (if used), we utilize CRISPR technology to delete or downregulate metabolic pathways leading to non-target organic acids (e.g., oxalate), ensuring high purity.
Co-factor Recycling Enhancement
We integrate and optimize systems for efficient NAD}^{+ regeneration within the host or enzymatic system, ensuring the continuous operation of Uronate Dehydrogenase.
This systematic approach focuses on improving the catalytic core (GOx) and optimizing the surrounding reaction environment for high specificity and conversion.
Our Glucuronic Acid engineering service is dedicated to pursuing the following production goals:
Enhanced Catalytic Efficiency
Directed evolution yields GOx variants with higher reaction speeds (k}_{\text{cat}) and improved affinity for the substrate, boosting conversion rate.
High Product Purity
Targeted knockouts and optimal conditions significantly minimize byproduct formation , simplifying costly downstream purification steps.
Operational Stability
Engineered enzymes exhibit better tolerance to temperature, pH variation , and substrate concentration, allowing for more robust industrial processes. [Image of Cost Reduction Icon]
Reduced Aeration Costs
If GOx is integrated into a microbial host, balanced O}_2$ consumption/supply can be achieved, potentially lowering the energy required for large-scale aeration .
Sustainable Production Route
Glucuronic Acid is produced from simple, renewable glucose , offering a green alternative to chemical routes.
We provide a specialized platform for the high-specificity and high-yield production of Glucuronic Acid.
Our Glucuronic Acid engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding enzyme performance and product specificity.
Explore the potential for a high-performance, high-purity Glucuronic Acid supply. CD Biosynsis provides customized production solutions:
What role does Glucuronic Acid play in the body?
It is vital for the detoxification process. Glucuronic Acid is conjugated (attached) to toxins, drugs, and hormones, increasing their water solubility and allowing the body to excrete them easily via urine or bile.
Why is Glucose Oxidase (GOx) central to this process?
GOx catalyzes the first oxidation step of glucose to gluconolactone, which then spontaneously or enzymatically hydrolyzes to gluconic acid. This intermediate is then further oxidized to Glucuronic Acid in subsequent steps.
How does directed evolution improve GOx?
Directed evolution introduces random genetic changes and uses selection pressure to isolate variants that are more efficient (faster), more specific (fewer side products), or more stable (higher heat tolerance) than the wild-type enzyme.
What are the key byproducts to avoid?
The most common are gluconic acid and oxalic acid . Oxalic acid formation is highly undesirable as it complicates downstream processing and must be strictly removed for food and pharmaceutical applications.
What is the estimated project timeline?
A project involving enzyme directed evolution, high-throughput screening, and fermentation optimization typically requires 20-24 weeks for final high-performance enzyme or host delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.